BioLife Solutions, Inc. (BLFS) vs Novavax, Inc. (NVAX)

A side-by-side comparison of BioLife Solutions, Inc. and Novavax, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BLFS vs NVAX

growth of $100 · dividends reinvested · last 10y
BLFS +2119.0% (+36.3%/yr)NVAX -59.7% (-8.7%/yr)BLFS compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$2,219$40
BLFS NVAX

BLFS vs NVAX: by the numbers

  • •BLFS is the larger company ($1.89B vs $1.85B market cap).
  • •BLFS is profitable (49.06% net margin) while NVAX runs a net loss (-59.87%).
  • •NVAX grew revenue faster over the past five years (118.86% vs 6.78% CAGR).

Metrics side by side

Valuation

MetricBLFSNVAX
P/E ratio37.72N/A
Forward P/E64.35N/A
P/S ratio18.354.47
P/B ratio4.49N/A
EV / EBITDA170.26N/A

Profitability

MetricBLFSNVAX
Gross margin64.48%93.67%
Operating margin-1.12%50.14%
Net margin49.06%-59.87%
ROE12.01%N/A
ROIC1.72%-36.37%

Growth (annualized)

MetricBLFSNVAX
Revenue CAGR (5Y)6.78%118.86%
Total return CAGR (5Y)-0.77%-40.61%

Frequently asked

Which has grown faster, BLFS or NVAX?
Over the past five years, NVAX grew revenue faster — BLFS at a 6.78% CAGR versus NVAX at 118.86%.
Is BLFS or NVAX more profitable?
BLFS runs the higher net margin — BLFS at 49.06% versus NVAX at -59.87%.
How have BLFS and NVAX total returns compared?
Over the past 10 years, BLFS delivered 36.27% and NVAX delivered -10.98% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.